Others

Items 8501-8550 of 13502

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Drug Intermediate

    6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one is a valuable drug intermediate that facilitates the synthesis of diverse active pharmaceutical compounds. This compound serves as a critical building block in the development of potential therapeutic agents, enabling further exploration in medicinal chemistry and drug discovery. Its unique structural features position it as a key reagent in various chemical research applications.
  2. Drug Intermediate

    2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural framework facilitates the development of novel therapeutic agents, making it valuable in medicinal chemistry. This compound is useful for researchers focusing on the design and synthesis of structurally related bioactive molecules.
  3. Drug Intermediate

    3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a versatile drug intermediate known for facilitating the synthesis of various bioactive compounds. This reagent exhibits valuable potential in medicinal chemistry and pharmaceutical development, enabling researchers to explore novel therapeutic agents. Its unique structural features make it an essential component in the synthesis of pyridine-based derivatives, contributing to advancements in drug discovery and development.
  4. Drug Intermediate

    2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. With its unique chemical structure, it is utilized in medicinal chemistry to facilitate the development of novel therapeutics. This compound supports research aimed at enhancing biological efficacy and optimizing pharmacological profiles of drug candidates.
  5. Drug Intermediate

    Ethyl 5-aminobenzofuran-2-carboxylate is a key intermediate in the synthesis of various drug compounds, particularly those related to serotonin reuptake inhibition. This reagent plays a significant role in the production of pharmacologically active substances and has applications in medicinal chemistry and drug development research. Its structural properties make it a valuable tool for the exploration of novel therapeutic options.
  6. Drug Intermediate

    Methyl 4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate is a key drug intermediate utilized in the synthesis of various biologically active compounds. This reagent facilitates the formation of complex structures, making it valuable in medicinal chemistry and pharmaceutical research. Its utility in drug development highlights its significance in the creation of novel therapeutic agents.
  7. Drug Intermediate

    (R)-1-(tert-Butoxycarbonyl)-2-methylpiperidine-2-carboxylic acid serves as a versatile drug intermediate critical for the synthesis of diverse active pharmaceutical compounds. This reagent's structural attributes facilitate various modifications, enhancing the development of therapeutic agents. It is useful in pharmaceutical research applications, particularly in the production of piperidine derivatives and related molecules.
  8. Drug Intermediate

    3-Acetamidophthalic anhydride acts as a key intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound plays a crucial role in facilitating the development of various bioactive molecules, making it essential for drug discovery and chemical research applications. Its versatility in chemical reactions supports its use in generating complex pharmaceutical structures.
  9. Drug Intermediate

    (S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid serves as an important drug intermediate in pharmaceutical synthesis. This compound facilitates the creation of diverse active pharmaceutical ingredients, making it valuable in the development of novel therapeutics. Its structural features support biochemical applications, particularly in the synthesis of imidazole-containing compounds.
  10. Drug Intermediate

    N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine serves as a critical drug intermediate in the synthesis of various bioactive compounds. This compound is utilized in medicinal chemistry for developing therapeutic agents due to its unique structural properties. Researchers can incorporate it into synthetic pathways to explore its potential in drug development and other chemical research applications.
  11. Drug Intermediate

    4-[(Trans-4-aminocyclohexyl)oxy]-2-chloro-Benzonitrile hydrochloride is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. Its chemical structure enables the modification and development of target compounds in medicinal chemistry. Researchers can leverage this intermediate to facilitate the creation of novel therapeutic agents, contributing to advancements in drug discovery and development.
  12. Drug Intermediate

    3-Benzyl-6-bromo-2-methoxyquinoline is a versatile drug intermediate utilized in the synthesis of various active pharmaceutical compounds. This compound serves as a key building block in the development of quinoline-based drugs, which have been involved in diverse biological activities. Researchers can leverage this intermediate for medicinal chemistry and pharmaceutical research aimed at discovering new therapeutics.
  13. Drug Intermediate

    1-Benzyl-2-methyl-1H-imidazole-5-carbaldehyde serves as a valuable drug intermediate in the synthesis of various bioactive compounds. Its structural properties facilitate the development of imidazole derivatives, which can exhibit a range of pharmacological activities. This reagent is widely utilized in medicinal chemistry and drug discovery research.
  14. Drug Intermediate

    2-Cyclopropylacetic acid is a versatile drug intermediate primarily used in the synthesis of various active pharmaceutical ingredients. This compound facilitates the development of novel therapeutics by serving as a key building block in organic synthesis. Its unique cyclopropyl structure contributes to the pharmacological properties of the resultant compounds, making it a valuable reagent in drug development research.
  15. Drug Impurity

    Rebamipide impurity 1 is a chemical impurity associated with Rebamipide, a gastroprotective agent. This impurity is crucial for analytical and quality control purposes in the evaluation of drug purity and formulation. Researchers can utilize this compound to assess the integrity and stability of Rebamipide in various biological studies and formulations.
  16. Drug Intermediate

    2-(Isopropylthio)aniline hydrochloride serves as a valuable drug intermediate, facilitating the synthesis of numerous active pharmaceutical compounds. Its chemical structure allows for versatility in drug development, making it an essential reagent in medicinal chemistry research. This compound aids in the design and construction of novel therapeutics and contributes to the advancement of pharmaceutical sciences.
  17. Drug Intermediate

    tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate is a versatile drug intermediate primarily used in the synthesis of pharmaceutical agents. This compound serves as a building block in the formation of various biologically active molecules, facilitating research in medicinal chemistry and drug discovery. It is particularly relevant for studies focusing on compounds with potential therapeutic applications.
  18. Drug Intermediate

    3-Methylcinnamic acid functions as a key intermediate in the synthesis of various bioactive compounds. Its structural features facilitate the development of pharmaceuticals and agrochemicals, enabling researchers to explore a diverse range of chemical reactions. It is widely utilized in organic synthesis, contributing to advancements in medicinal chemistry and material sciences.
  19. Drug Intermediate

    2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine serves as a critical drug intermediate in the synthesis of various active pharmaceutical ingredients. This compound facilitates the creation of bioactive molecules by enabling specific chemical transformations. Its unique structure and reactivity make it valuable for researchers working in medicinal chemistry and drug development.
  20. Drug Intermediate

    Ethyl 6-(4-Aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate serves as a key drug intermediate in the synthesis of diverse bioactive molecules. Its unique structure facilitates the development of compounds with potential therapeutic applications. This reagent is particularly valuable in medicinal chemistry for the creation of novel pharmacological agents.
  21. Drug Intermediate

    2-Bromo-3-methoxycyclopent-2-enone serves as a versatile drug intermediate in the synthesis of various bioactive compounds. Its cyclopentene structure and bromine substitution facilitate chemical transformations critical for developing novel pharmaceuticals. This reagent is valuable for research in medicinal chemistry and drug discovery, assisting in the exploration of potential therapeutic agents.
  22. Drug Intermediate

    4-Methoxyphenyl carbonochloridate serves as a versatile drug intermediate, facilitating the synthesis of a range of bioactive compounds. This compound is particularly valuable in pharmaceutical research, enabling the generation of novel therapeutic agents. Its reactive carbonochloridate group allows for effective coupling reactions, making it ideal for medicinal chemistry applications.
  23. Drug Intermediate

    (2-Azabicyclo[2.1.1]Hexan-1-yl)methanol hydrochloride is a valuable drug intermediate utilized in the synthesis of diverse pharmaceutical compounds. Its unique bicyclic structure facilitates the production of biologically active molecules for various applications in medicinal chemistry and drug development. This compound serves as an essential building block for the generation of therapeutic agents.
  24. Drug Intermediate

    6-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride serves as a drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its chemical structure enables the development of various therapeutic agents, making it a valuable cornerstone in medicinal chemistry. This reagent is instrumental in research applications focusing on the design and synthesis of isoquinoline-derived molecules.
  25. Drug Intermediate

    5-Methoxy-2-nitro-4-((triisopropylsilyl)oxy)benzoic acid serves as a valuable drug intermediate for the synthesis of diverse bioactive molecules. Its unique chemical structure facilitates the development of various pharmaceutical compounds. Researchers utilize this reagent in the synthesis of targeted therapeutics, advancing studies in medicinal chemistry and drug discovery.
  26. Drug Intermediate

    (R)-tert-Butyl 3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate serves as a crucial drug intermediate in the synthesis of bioactive compounds. It is designed to facilitate the development of novel therapeutic agents targeting specific biological pathways. This reagent is essential for research applications focused on medicinal chemistry and pharmacological studies.
  27. Drug Intermediate

    ((6-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-((triisopropylsilyl)ethynyl)naphthalen-2-yl)oxy)triisopropylsilane serves as a valuable drug intermediate, primarily targeting synthetic pathways for the development of various bioactive compounds. Its unique structure facilitates the introduction of complex functional groups, making it essential in medicinal chemistry and pharmaceutical research. This reagent is suitable for applications involving the synthesis of derivatives that may exhibit a range of biological activities.
  28. Drug Intermediate

    1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid is a key drug intermediate utilized in the synthesis of various bioactive compounds. This reagent plays an essential role in the production of pharmaceuticals, particularly in the development of therapeutic agents. Its structural features facilitate the creation of diverse molecular frameworks for research applications in drug discovery and development.
  29. Drug Impurity

    Apixaban impurity 28 is a chemical impurity associated with the anticoagulant agent Apixaban. This compound serves as a reference standard for analytical characterization and quality control of Apixaban formulations. Its identification and quantification are critical for ensuring the integrity and safety of pharmaceutical products containing Apixaban, making it valuable for research and development in drug formulation and regulatory compliance.
  30. Drug Intermediate

    (2R,7aS)-2-Fluorotetrahydro-1H-pyrrolizine-7a(5H)-methanol serves as a pivotal drug intermediate in the synthesis of various bioactive compounds. This compound features prominently in the design of therapeutics aimed at targeting the KRAS G12D mutation, offering potential pathways for innovative cancer treatments. Its structural characteristics make it an essential building block in medicinal chemistry and pharmaceutical development.
  31. Drug Impurity

    Ribociclib impurity 1 is a known impurity associated with the CDK4/6 inhibitor Ribociclib. This compound serves as a reference standard for quality control and characterization of Ribociclib formulations. It is essential in analytical applications to ensure the purity and efficacy of ribociclib in pharmaceutical development and research.
  32. Drug Intermediate

    (s)-2-Amino-5-methoxytetralin hydrochloride serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This compound exhibits versatile reactivity, making it suitable for use in medicinal chemistry research. It plays a significant role in facilitating the development of pharmaceuticals by enabling the construction of complex molecular architectures.
  33. Drug Intermediate

    (S)-2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine hydrochloride is a versatile drug intermediate primarily used in the synthesis of various bioactive compounds. This reagent plays a critical role in the development of therapeutic agents, enabling advancements in pharmacological research. Its unique structural features facilitate enzyme interactions and receptor binding, making it a valuable tool for researchers in medicinal chemistry.
  34. Drug Intermediate

    4-(3-Fluorobenzyloxy)benzaldehyde serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound is instrumental in medicinal chemistry research, facilitating the development of new therapeutic agents. Its chemical structure allows for versatile modifications, making it highly valuable in the exploration of novel drug candidates.
  35. Drug Intermediate

    ((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural components facilitate the development of complex molecular architectures, contributing to the advancement of new therapeutic agents. This reagent is applicable in pharmaceutical research, particularly in the fields of medicinal chemistry and drug design.
  36. Drug Intermediate

    (1S,6R)-6-Amino-2,2-difluorocyclohexan-1-ol is a versatile drug intermediate utilized in the synthesis of diverse pharmacologically active compounds. Its unique structural properties facilitate the development of novel therapeutics by providing a crucial building block in medicinal chemistry. This compound plays a significant role in the design and optimization of drug candidates targeting various diseases.
  37. Drug Intermediate

    1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its structural properties facilitate the development of pharmacologically relevant intermediates, making it valuable in medicinal chemistry research. This compound is primarily utilized in the exploration of novel therapeutic agents and drug discovery applications.
  38. Drug Intermediate

    (S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride serves as a valuable drug intermediate in the synthesis of various biologically active compounds. Its structural features facilitate the production of diverse pharmaceuticals, making it a crucial reagent in medicinal chemistry research. The compound allows for the exploration of new therapeutic agents and aids in the development of innovative treatment methodologies.
  39. Drug Intermediate

    2-Vinylphenyl acetate serves as a crucial drug intermediate in the synthesis of a variety of active pharmaceutical compounds. It plays a significant role in organic synthesis, particularly in the formation of vinyl ether derivatives. This reagent is utilized in the development of pharmaceuticals and biologically active molecules, facilitating advanced chemical research and drug development processes.
  40. Drug Intermediate

    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine (hydrochloride) serves as a key intermediate in the synthesis of diverse biologically active compounds. Its structural features enable it to participate in chemical reactions essential for the development of therapeutic agents. This reagent is valuable for researchers involved in drug discovery and the synthesis of novel pharmaceuticals.
  41. Drug Intermediate

    rel-(2R,3S)-1,2,3,4-Tetrahydro-1,4-methanonaphthalene-2,3-diol serves as a crucial intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural features facilitate multiple chemical transformations, making it valuable for developing novel therapeutic agents. Researchers engaged in drug discovery and development can leverage this compound for the efficient production of bioactive molecules.
  42. Drug Intermediate

    2-Fluoro-5-formylbenzoic acid serves as an important drug intermediate in the synthesis of various pharmaceutical compounds. This compound can facilitate the formation of biologically active molecules, making it valuable in medicinal chemistry research. Its unique structural characteristics may contribute to the development of novel therapeutics.
  43. Drug Intermediate

    4-Chlorobenzoic acid is a halogenated aromatic compound primarily utilized as a drug intermediate in pharmaceutical synthesis. This compound exhibits potential as a persistent organic micropollutant, offering insights into environmental biodegradation mechanisms, particularly through direct dehalogenation pathways. Its applications in chemical research and development highlight its relevance in the creation of various pharmacologically active compounds.
  44. Drug Intermediate

    1-Boc-3-benzyl-3-piperidinecarboxylic acid serves as a valuable drug intermediate in the synthesis of diverse bioactive compounds. This chemical structure offers a piperidine backbone that can enhance pharmacological properties. It is widely utilized in the development of pharmaceuticals and in medicinal chemistry research for creating novel therapeutic agents.
  45. Drug Intermediate

    tert-Butyl (1S,4S,5R)-5-hydroxy-2-azabicyclo[2.2.1]heptane-2-carboxylate serves as a valuable drug intermediate in the synthesis of diverse pharmacologically active compounds. Its unique bicyclic structure and hydroxyl group contribute to its reactivity and versatility in chemical reactions. This compound is essential for researchers developing novel therapeutic agents and exploring structure-activity relationships in medicinal chemistry.
  46. Drug Intermediate

    2-((4-((2-Isopropoxyethoxy)methyl)phenoxy)methyl)oxirane is a versatile drug intermediate utilized in the synthesis of various pharmacologically active compounds. This epoxide structure facilitates the introduction of functional groups, making it valuable for medicinal chemistry applications. Its reactivity and compatibility with different synthetic routes support efforts in drug development and optimization.
  47. Drug Intermediate

    (4-Cyclopropyl-6-methoxypyrimidin-5-yl)boronic acid functions as a versatile drug intermediate in the synthesis of diverse bioactive compounds. It serves as a key building block in medicinal chemistry, facilitating the development of novel therapeutics due to its unique structural framework. This reagent is valuable for researchers focused on optimizing compound efficacy and exploring new pharmacological pathways.
  48. Drug Intermediate

    4-Hydroxy-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide serves as an important drug intermediate in the synthesis of diverse bioactive compounds. This reagent facilitates the development of potential therapeutic agents by providing a versatile scaffold for further chemical modifications. Its application is valuable in medicinal chemistry and drug development research.
  49. Drug Intermediate

    1H-Pyrazole-4-boronic acid pinacol ester is a key intermediate in the synthesis of small-molecule inhibitors targeting Mps1 kinase. This compound plays a crucial role in the development of novel therapeutic agents aimed at modulating cell cycle regulation and cancer proliferation. Its utility in medicinal chemistry facilitates the advancement of research into potential oncological treatments.
  50. Drug Intermediate

    (Rp,R'p)-(R)-Mandyphos serves as a drug intermediate, primarily utilized in the synthesis of various bioactive compounds. This compound features a distinctive ferrocene backbone, which enhances its potential for medicinal chemistry applications. It is an essential building block in the development of pharmaceuticals, facilitating the exploration of new therapeutic agents.

Items 8501-8550 of 13502

Page
per page
Set Descending Direction